Compare CTLP & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTLP | MGTX |
|---|---|---|
| Founded | 1992 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.9M | 665.7M |
| IPO Year | N/A | N/A |
| Metric | CTLP | MGTX |
|---|---|---|
| Price | $10.60 | $7.77 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | N/A | ★ $23.83 |
| AVG Volume (30 Days) | ★ 519.3K | 518.4K |
| Earning Date | 02-05-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 371.48 | N/A |
| EPS | ★ 0.80 | N/A |
| Revenue | ★ $312,565,000.00 | $27,417,000.00 |
| Revenue This Year | $18.25 | N/A |
| Revenue Next Year | $12.30 | $619.95 |
| P/E Ratio | $13.27 | ★ N/A |
| Revenue Growth | 12.94 | ★ 96.83 |
| 52 Week Low | $7.01 | $4.55 |
| 52 Week High | $11.36 | $9.73 |
| Indicator | CTLP | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 49.17 | 42.57 |
| Support Level | $10.54 | $7.77 |
| Resistance Level | $10.63 | $8.40 |
| Average True Range (ATR) | 0.07 | 0.53 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 50.00 | 0.88 |
Cantaloupe Inc is a technology leader powering self-service commerce by offering one integrated solution for payments processing, logistics, and back-office management. The group offers a comprehensive suite of solutions, including micro-payment processing, self-checkout kiosks, mobile ordering, connected point-of-sale (POS) systems, and enterprise cloud software. Its product and services portfolio consists of Card Readers, Self-Service Kiosks, Smart Coolers, Seed Pick Easy, Cantaloupe Go, Cheq, Smart Lock Connect, and Vine Digital Studio. The company derives revenue streams from subscriptions, transaction processing, and equipment sales.
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.